Literature DB >> 17315032

A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid.

Yasuhiro Ito1, Akira Miyauchi.   

Abstract

Papillary microcarcinoma of the thyroid (PMCT) is defined as papillary carcinoma measuring 1.0 cm or less. PCMT are frequently detected by ultrasonographic screening and ultrasonography-guided fine-needle aspiration biopsy. Although PMCT can pathologically show a high incidence of multifocality and lymph node metastasis in surgical specimens, most tumors grow slowly or not at all when they are monitored without surgery. In our observations only 6.7% of PMCT enlarged by 3.0 mm or more in diameter during 5 years of follow-up, and nodal metastases became detectable in 1.7% of patients overall. Observation without surgery could, therefore, be an attractive alternative for patients with low-risk PMCT; however, occult PMCT, which are diagnosed as the origin of lymph node or distant metastasis, show a worse prognosis. Even among incidentally detected PMCT, tumors with ultrasonographically detectable nodal metastasis are more likely to recur. Because such PMCT are most likely to recur in the regional lymph nodes, careful therapeutic neck dissection and total thyroidectomy are required. For incidentally detected and low-risk PMCT, careful observation without surgery might be acceptable, but careful and systematic surgery should be performed for patients with PMCT demonstrating aggressive characteristics.

Entities:  

Mesh:

Year:  2007        PMID: 17315032     DOI: 10.1038/ncpendmet0428

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  40 in total

1.  Is surgery necessary for papillary thyroid microcarcinomas?

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  Nat Rev Endocrinol       Date:  2011-12-06       Impact factor: 43.330

2.  Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best?

Authors:  Ian D Hay
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 3.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

4.  Treatment decision making in early-stage papillary thyroid cancer.

Authors:  Thomas A D'Agostino; Elyse Shuk; Erin K Maloney; Rebecca Zeuren; R Michael Tuttle; Carma L Bylund
Journal:  Psychooncology       Date:  2017-02-27       Impact factor: 3.894

5.  Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.

Authors:  Yasuhiro Ito; Akira Miyauchi; Minoru Kihara; Takuya Higashiyama; Kaoru Kobayashi; Akihiro Miya
Journal:  Thyroid       Date:  2013-11-14       Impact factor: 6.568

6.  An observational trial for papillary thyroid microcarcinoma in Japanese patients.

Authors:  Yasuhiro Ito; Akira Miyauchi; Hiroyuki Inoue; Mitsuhiro Fukushima; Minoru Kihara; Takuya Higashiyama; Chisato Tomoda; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

Review 7.  How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.

Authors:  Kennichi Kakudo
Journal:  Gland Surg       Date:  2018-08

8.  Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

Authors:  Celestino P Lombardi; Rocco Bellantone; Carmela De Crea; Nunzia C Paladino; Guido Fadda; Massimo Salvatori; Marco Raffaelli
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 9.  Thyroid ultrasonography.

Authors:  Yasuhiro Ito; Nobuyuki Amino; Akira Miyauchi
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

10.  Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes.

Authors:  Iwao Sugitani; Kazuhisa Toda; Keiko Yamada; Noriko Yamamoto; Motoko Ikenaga; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.